Is Right-Sided Pleural Mesothelioma Worse than Left-Sided?

Is Right-Sided Pleural Mesothelioma Worse than Left-Sided?

Pleural mesothelioma develops from the thin layer of tissue that covers the lungs and chest wall. Pleural mesothelioma may develop in the lining of the chest wall on just one side of the chest. Previous research has suggested that right-sided pleural mesothelioma is associated with a poorer prognosis. Yet, these were very small studies and estimates were not precise. Dr. Adjepong’s team decided to see if the side mattered. Does it matter if pleural mesothelioma is more on the left or right side? Using National SEER Database to Study Pleural Mesothelioma Malignant pleural mesothelioma is a highly aggressive and rare form of cancer. There are approximately 2,000 cases of mesothelioma diagnosed in the U.S. every year. Mesothelioma is caused by exposure to … Continue reading Is Right-Sided Pleural Mesothelioma Worse than Left-Sided? »

Reviewing Twenty Years of Malignant Mesothelioma in American Women

Malignant Mesothelioma Mortality in American Women

A new study shows twenty years of national trends associated with an increase of mesothelioma deaths in American women. Inhalation of asbestos fibers can cause malignant mesothelioma. Mesothelioma is a rapidly progressing and lethal cancer. It occurs in the mesothelium, a thin layer of tissues surrounding internal organs. It is usually found in the chest and abdomen. Patients with malignant mesothelioma have a poor prognosis. They have an average survival of one year from diagnosis. The estimated average timespan from initial asbestos exposure to death is 32 years. Occupational asbestos exposure is most often reported in men. This is because they often work in industries such as construction and manufacturing. But American women are also at risk for asbestos fiber … Continue reading Reviewing Twenty Years of Malignant Mesothelioma in American Women »

Mesothelioma Patients Underrepresented in European National Cancer Data

Mesothelioma Patients Underrepresented in European National Cancer Data

Cancer patient surveys are important for improving healthcare practice and policy. A new study suggests mesothelioma patients may be underrepresented in this important survey. The goal of the National Cancer Patient Experience Survey is to improve European cancer care. In order to be useful, this survey should represent all cancer patients. Cancer Patient Data Collection using a National Survey Patient feedback from healthcare services is important for informing healthcare quality. And data from patient surveys directly impact policy to improve care. In the United Kingdom, there are many surveys that collect information on patient experiences. For people with cancer, a National Cancer Patient Experience Survey has been taken annually for the last 12 years. It surveys over 65,000 people with … Continue reading Mesothelioma Patients Underrepresented in European National Cancer Data »

Gender Differences in Men versus Women with Mesothelioma

Gender Differences in Men versus Women with Mesothelioma

Asbestos is toxic and cancer-causing for human beings. Asbestos causes mesothelioma and other asbestos related diseases. Asbestos-related diseases affect men and women differently. A recent study looked at Brazilian patients with asbestos-related diseases. These included mesothelioma, asbestosis, and lung and ovarian cancer. Introduction Mesothelioma, asbestosis, and pleural plaques are the main asbestos-related diseases. Many consider mesothelioma as the fingerprint of asbestos usage. Between 1961 and 2017, more 7 million tons of asbestos were consumed in Brazil. Mesothelioma from occupational exposure is most common in men. They were often exposed to asbestos at the job site. The number of non-occupational exposures is higher in women. Women are often exposed to asbestos from domestic and environmental sources. It has been difficult to … Continue reading Gender Differences in Men versus Women with Mesothelioma »

Mesothelioma Clinical Trials: Are Minorities Underrepresented?

mesothelioma clinical trials

The results of a new study from Harvard and Dana Farber Cancer Institute raise the question of whether ethnic minorities are being fairly represented in mesothelioma clinical trials. The study focused on four of the most common types of cancer in the US: breast, prostate, lung, and colorectal cancer.  It looked at demographic data for close to 6,000 people enrolled in precision oncology trials for these cancers. Researchers found that clinical trials tend to favor white and Asian patients over Hispanic and black patients.  The study could have implications for mesothelioma clinical trials of new, tailored treatments.  Precision Oncology and Mesothelioma Clinical Trials Malignant mesothelioma is a challenging cancer to treat. Mesothelioma cells are good at protecting themselves from damaging … Continue reading Mesothelioma Clinical Trials: Are Minorities Underrepresented? »

Asbestos Bans Not a Quick Fix for Rising Mesothelioma Incidence

mesothelioma incidence

A new study is further evidence that asbestos bans are not a quick fix for the global problem of malignant mesothelioma incidence.  Researchers in China and the US just released a worldwide research study on the asbestos cancer. The study included 21 regions in 195 countries and territories and spanned 27 years.  The authors say mesothelioma incidence does decrease after asbestos bans. But the decrease can take decades. In the meantime, they say many countries need to do a better job of tracking and managing mesothelioma cases.  Asbestos and Mesothelioma Incidence Malignant mesothelioma is an aggressive cancer with a poor prognosis. Exposure to asbestos is its only known cause. People with mesothelioma often die of this cancer in less than … Continue reading Asbestos Bans Not a Quick Fix for Rising Mesothelioma Incidence »

One in Three Mesothelioma Deaths Go Unreported in Brazil

mesothelioma deaths

Brazil has a history of underreporting mesothelioma deaths and the trend is not improving.  That is the word from Brazilian public health experts. Their new report appears in a recent issue of Occupational Medicine.  Researchers from the Institute of Collective Health in Salvador examined electronic medical records from across the country. They compared them with the official record of asbestos related diseases (ARDs) in Brazil’s Mortality Information System.  They discovered that more than 300 mesothelioma deaths were missing from the roughly 1000 deaths reported between 2008 and 2014. The researchers say such underreporting makes it harder to evaluate “remedial policies” that could help prevent asbestos-linked illnesses. Asbestos in Brazil Asbestos is the primary cause of mesothelioma deaths worldwide. Mesothelioma is a … Continue reading One in Three Mesothelioma Deaths Go Unreported in Brazil »

How Long Does Mesothelioma Risk Last After Asbestos Exposure?

asbestos exposure

If you experienced asbestos exposure more than 30 years ago and you have not developed mesothelioma, your risk for the disease may be starting to decline.  A new Italian study is the latest to suggest that mesothelioma risk may taper off over time. A group of occupational health experts conducted the study. Their goal was to predict mesothelioma trends in Italy until 2040.  The data shows that mesothelioma cases will probably peak this year. But they also show that most of those cases will happen in people with asbestos exposure in the last three decades.  Asbestos Exposure and Mesothelioma Incidence Asbestos is the main cause of malignant mesothelioma. A small number of mesothelioma cases happen without any known asbestos exposure. … Continue reading How Long Does Mesothelioma Risk Last After Asbestos Exposure? »

Annual Report on Cancer Death Rates: Good and Bad News for Mesothelioma Patients

cancer death rates

The latest report on cancer death rates in the US is both good and bad news for people with malignant mesothelioma.  The good news is that the rate of death from all types of cancer has declined in recent years. This is true for both men and women of all races. Better drugs and improved screening tools are some of the reasons.  The bad news for people with mesothelioma is that the likelihood of dying from it is not declining as rapidly as overall cancer death rates. Asbestos cancer continues to confound cancer researchers around the world.  Mesothelioma: A Rare Cancer with High Mortality Malignant mesothelioma is one of the rarest cancers in the US. That is fortunate because the … Continue reading Annual Report on Cancer Death Rates: Good and Bad News for Mesothelioma Patients »

South Korean Mesothelioma Rates Still Rising Decades After Asbestos Ban

asbestos ban

A new report out of South Korea is proof that it can take many years for mesothelioma rates to decline even after implementing an asbestos ban. Asbestos is the number one cause of malignant mesothelioma worldwide. South Korea banned asbestos in 2009. But a report in the International Journal of Environmental Research and Public Health shows the country will likely be dealing with the after-effects well into the future.  A national asbestos ban is a vital step toward fighting occupational cancer. But the new study is a sobering reminder that it cannot eliminate mesothelioma overnight.  Occupational Risk for Malignant Mesothelioma Mesothelioma can be a health hazard for anyone who ever worked with or around asbestos.  Once a worker inhales or … Continue reading South Korean Mesothelioma Rates Still Rising Decades After Asbestos Ban »

Get your free copy of
“Surviving Mesothelioma” Today!